A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial (vol 261, pg 2101, 2014)

Ziemssen Tjalf<sup>*</sup>; Bajenaru Ovidiu A; Carra Adriana; de Klippel Nina; de Sa Joao Correia; Edland Astrid; Frederiksen Jette L; Heinzlef Olivier; Karageorgiou Klimentini E; Delgado Rafael H Lander; Landtblom Anne Marie; Macias Islas Miguel A; Tubridy Niall; Gilgun Sherki Yossi

doi:10.1007/s00415-014-7565-7

免费注册

赞收藏引用

科研之友

微信

新浪微博

Facebook

分享链接

A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial (vol 261, pg 2101, 2014)

作者：Ziemssen Tjalf^*; Bajenaru Ovidiu A; Carra Adriana; de Klippel Nina; de Sa Joao Correia; Edland Astrid; Frederiksen Jette L; Heinzlef Olivier; Karageorgiou Klimentini E; Delgado Rafael H Lander; Landtblom Anne Marie; Macias Islas Miguel A; Tubridy Niall; Gilgun Sherki Yossi

来源：Journal of Neurology, 2015, 262(1): 248-248.

DOI：10.1007/s00415-014-7565-7